CD19 and leukemia: A paper published by our group, led by Dr. Elena Sotillo at the Children Hospital of Philadelphia, demonstrated that, at least in a subset of CD19-negative leukemias emerging after CD19-directed therapy, mutations affecting the CD19 gene and CD19 splicing variants lacking the CAR-recognized epitope are strongly enriched compared to samples before CART19 treatment.